,outcome,arm 1,arm 2
0,intervention,,placebo group
0,responders ( daily dose,NR,"2.9+/-1.4 mg, none of 16"
0,"responders ( daily dose, total study group",8 ( 57 % ) of 14 patients,8 ( 57 % ) of 14 patients
